GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (LSE:IMM) » Definitions » Other Current Payables

ImmuPharma (LSE:IMM) Other Current Payables : £0.00 Mil (As of Jun. 2023)


View and export this data going back to 2003. Start your Free Trial

What is ImmuPharma Other Current Payables?

ImmuPharma's Other Current Payables for the quarter that ended in Jun. 2023 was £0.00 Mil.

ImmuPharma's annual Other Current Payables increased from Dec. 2020 (£0.00 Mil) to Dec. 2021 (£0.00 Mil) but then declined from Dec. 2021 (£0.00 Mil) to Dec. 2022 (£0.00 Mil).


ImmuPharma Other Current Payables Historical Data

The historical data trend for ImmuPharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuPharma Other Current Payables Chart

ImmuPharma Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ImmuPharma Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ImmuPharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


ImmuPharma Other Current Payables Related Terms

Thank you for viewing the detailed overview of ImmuPharma's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmuPharma (LSE:IMM) Business Description

Traded in Other Exchanges
Address
One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus and a life-threatening autoimmune disease.

ImmuPharma (LSE:IMM) Headlines

No Headlines